Melanoma by the State: Oregon
Let’s start with some fun facts about Oregon: Oregon boasts the deepest lake in the U.S., Crater Lake, with a…
Blog - Melanoma360
09/24/2021
Melanoma by the State: Oregon
Let’s start with some fun facts about Oregon: Oregon boasts the deepest lake in the U.S., Crater Lake, with a…
|
09/24/2021
Motherhood and Melanoma: Raleigh Minning, Stage III Melanoma Survivor
By Mara Klecker One of the only times Raleigh Minning cried during her melanoma journey was when she thought of…
|
09/20/2021
Immunotherapy treatment may be appropriate for patients with earlier stages of melanoma
Source: University of Pittsburgh (September 20, 2021) An immunotherapy called pembrolizumab reduced cancer recurrence after surgery in patients with stage…
|
|
09/20/2021
USDA Accepts for Priority Review Bristol Myers Squibb’s Application for LAG-3-Blocking Antibody Relatlimab and Nivolumab Fixed-Dose Combination as Treatment for Patients with Unresectable or Metastatic Melanoma
09/20/2021 The application is based on Phase 2/3 RELATIVITY-047 trial, in which the relatlimab and nivolumab fixed-dose combination demonstrated a…
|
|
09/18/2021
Adjuvant Immunotherapy Prolongs Recurrence-Free Survival in Resected Stage II B/C Melanoma
LUGANO, Switzerland – The first randomised phase III clinical trial in stage II melanoma has shown a 35% reduction in the…
|
|
08/25/2021
Nouscom Begins Phase Ib Trial of Personalized Vaccine, Keytruda Combo in Melanoma, Lung Cancer
August 24, 2021 Expands DecisionDx®-Melanoma Coverage to Veterans Health Administration and Military Health System Medical Centers NEW YORK – Nouscom…
|
|
08/25/2021
Castle Biosciences Awarded U.S. Federal Supply Schedule Contract for DecisionDx-Melanoma
August 24, 2021 07:00 AM Eastern Daylight Time Expands DecisionDx®-Melanoma Coverage to Veterans Health Administration and Military Health System Medical…
|
|
07/29/2021
In Plain English—June 2021 News from ASCO, the American Society of Clinical Oncology
By Kim Margolin, M.D. You might have seen the term ASCO as you’ve scrolled through melanoma websites or research documents…
|
07/23/2021
President’s Letter | July 2021
From the Desk of Samantha Guild I was struck several times this month with the idea that the fight against…
|
07/22/2021
FDA Orphan Drug Designation Granted to Melanoma Drug Alrizomadlin
July 21, 2021 (repost) Sara Karlovitch The FDA has granted an orphan drug designation to alrizomadlin, an MDM2-p53 inhibitor, for…
|
|
Recent Posts
Jul. 10, 2026
Help Bring a New Treatment Option to Patients with Advanced Melanoma
Jul. 06, 2026
How Melanoma Changed Adam Harper’s Perspective on Life
Jun. 26, 2026
FDA Accepts Review of RP1 for Advanced Melanoma; Decision Expected August 2026
Jun. 23, 2026
Insights from the 2026 American Academy of Dermatology (AAD) Annual Practice Safe Sun Survey
Jun. 09, 2026